John F DiPersio

31PUBLICATIONS
228CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

|Apr 03, 2026
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.

Ashish O Gupta, Akshay Sharma, Haydar Frangoul

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Feb 17, 2026
Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.

Yuping Derek Li, David A Giles, Yi Huang

|Jan 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell function.

Tien-Ching Chang, Amanda Heard, John Lattin

|Jan 09, 2026
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.

William C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova

Pageof 6

Frequent Collaborators

8 joint publications

Michael Rettig

5 joint publications

Matthew A Wyczalkowski

5 joint publications

Li Ding

4 joint publications

Reyka G Jayasinghe